Impact of the FIGO2023 staging system on endometrial cancer in Japan: differences between next-generation sequencing and simplified surrogate marker analysis.

Ryoken NaraAkiko FurusawaTsubasa HirakiNobutaka TakahashiKeiichi HatakeyamaKenichi UrakamiYasuyuki HirashimaKen Yamaguchi

Published in: Japanese journal of clinical oncology (2024)

The revision of the staging system from FIGO2008 to FIGO2023 and FIGO2023m resulted in the restaging of several cases, with significant changes between stages I and II.

Keyphrases

endometrial cancer
lymph node
pet ct
total knee arthroplasty
copy number
dna methylation
total hip arthroplasty
genome wide
cell free
data analysis